USD0.000æéå€ååŒÂ  (ET)
103.94MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
ALX Oncology Holdings Inc
ALXO ãã©ã³ã¹ã·ãŒã
ALX Oncology Holdings Incã®è²¡åå¥å
šæ§ãè©äŸ¡ãããã¡ã³ãã¡ã³ã¿ã«ãºãåæããæµåæ§ãã¬ãã¬ããžãæ ªäž»è³æ¬å©ççãªã©ã®äž»èŠæ¯çãèšç®ããããã«ããã¡ãã§ALX Oncology Holdings Incã®å¹Žæ¬¡ãŸãã¯ååæã®ãã©ã³ã¹ã·ãŒããã確èªããã ããŸãã
ãããã質å
ALXO æ ªãåæããéã«æãéèŠãªè²žå察ç
§è¡šã®ææšã¯äœã§ããïŒ
îéèŠãªææšã«ã¯ãçŸéããã³çææè³ãç·è³ç£ãæµåè³ç£ãç·è² åµãæµåè² åµãé·æåµåãæ ªäž»è³æ¬ãå©çå°äœéãåšåº«ã売äžåµæš©ãéè»¢è³æ¬ãæµåæ¯çãåœåº§æ¯çãè² åµè³æ¬æ¯çãèªå·±è³æ¬å©ççãå«ãŸããŸããæè³å®¶ã¯éåžžãããããç·åçã«èŠãŠã1ã€ã®æ°å€ã«é Œããªãããã«åæããŸãã
è³ç£ãè² åµãããã³æ ªäž»è³æ¬ã®éãã¯äœã§ããïŒ
îè³ç£ã¯ãçŸéã売äžåµæš©ãåšåº«ãæè³ãåºå®è³ç£ãªã©ãäŒæ¥ãææãŸãã¯ç®¡çããŠãããªãœãŒã¹ã§ããè² åµã¯ãäŒæ¥ãè² ã£ãŠãã矩åã§ãããè²·æéãåµåããªãŒã¹ããã³çšéãå«ãŸããŸããæ ªäž»è³æ¬ã¯ãè³ç£ããè² åµãå·®ãåŒããçŽè³ç£äŸ¡å€ã§ãã
æµåé
ç®ãšéæµåé
ç®ã®éãã¯äœã§ããïŒ
îæµåè³ç£ãšæµåè² åµã¯ãäžè¬çã«1幎ãŸãã¯1å¶æ¥ãµã€ã¯ã«ã®ãã¡ã«çŸéåã䜿çšãæ¯æãããŸãã¯æž
ç®ãããããšãæåŸ
ãããŸããéæµåè³ç£ããã³éæµåè² åµã¯ãåºå®è³ç£ãé·ææè³ãç¹°å»¶çšéè³ç£ããã³é·æåµåããªãŒã¹åµåãªã©ã®é·æé
ç®ã§ãã
ALX Oncology Holdings Inc ã¯ã©ããããã®çŸéãæã£ãŠããŸããïŒ
îæè¿ã®ååæã®å ±åã§ã¯ãALX Oncology Holdings Inc ã®çŸéåã³çŸéåçç©ã¯ 32.28M ã§ããã
ALX Oncology Holdings Inc ã®ç·è² åµã¯ãããã§ããïŒ
îALX Oncology Holdings Inc ã¯ææ°ã®å ±åååæã«ãããŠãç·è² åµã 33.06M ã§ãæµåè² åµã 24.55M ã§ãéæµåè² åµã 8.51M ã§ããããšãå ±åããŸããã
ALX Oncology Holdings Inc ã®ç·è³ç£ã¯ãããã§ããïŒ
îæè¿ã®å ±åååæã«ãããŠãALX Oncology Holdings Inc ã®ç·è³ç£ã¯ 59.05M ã§ãæµåè³ç£ã 50.73M ãéæµåè³ç£ã 8.32M ã§ããããšãå ±åããŸããã
ALX Oncology Holdings Inc ã®æ ªäž»è³æ¬ã¯ã©ã®ãããã§ããïŒ
îALX Oncology Holdings Inc ã¯ææ°ã®å ±åååæã«ãããŠãç·æ ªäž»è³æ¬ã 25.98M ã§ãããšå ±åããŸããã